# Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

> **NCT00684723** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lovastatin 40 mg Tablets
- **DRUG:** Lovastatin (Mevacor®) 40 mg Tablets

## Key facts

- **NCT ID:** NCT00684723
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2010-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684723, "Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00684723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*